Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger protein 572 (ZNF572) is a member of the zinc finger protein family, which is characterized by the presence of one or more zinc finger motifs facilitating binding to DNA, RNA, or other proteins. ZNF572 is predicted to act as a transcription factor, primarily involved in the negative regulation of transcription mediated by RNA polymerase II, as well as in the regulation of cytokine production and immune responses. Like other zinc finger transcription factors, ZNF572 likely functions by binding specific DNA sequences to modulate gene expression, but its individual biological roles and direct disease associations remain largely uncharacterized in the scientific literature as of this review. There is no evidence to date that ZNF572 is a direct or established therapeutic target or that it acts as a clinical biomarker.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger protein 572 (ZNF572).